Skip to Content
Innovation-Meet-Health-DotCom_Banner_2880-x-1800px
Event

HLTH Europe

Amsterdam, June 17-20, 2024

Download guide2 MB pdf

Capgemini at HLTH Europe 2024

Attending HLTH isn’t just another item on our calendar – it’s a big opportunity. We believe it’s a chance to really get involved in what’s next for healthcare and life sciences. It’s about sharing our thoughts, picking up insights from leaders in the field, and bringing all that knowledge back to work to improve what we do.

HLTH Europe is where the action is if you’re keen on being part of healthcare’s and life sciences’ exciting future. We’re there to show what Capgemini can do and help everyone see the difference we’re making in health and life sciences.

We’ve got our eyes on three key areas: Innovation, connected health, and data and AI. These topics are at the core of healthcare’s evolution. Think groundbreaking developments, better connections between patients and healthcare providers, and smarter use of technology to improve health outcomes.

By joining us for our talks and visiting our space at HLTH, you’re doing more than just attending an event. You’re stepping into the forefront of healthcare innovation with us. It’s about creating positive change, fostering connections, and leveraging technology in new ways to keep people healthy.

Download our HLTH guide
Sign up now

Explore and register for our sessions

Welcome to the heart of our HLTH Europe participation. Below, you’ll find a curated list of presentations designed to inspire, inform, and engage. Each session is a unique opportunity to explore the cutting-edge topics of innovation, connected health, and data and AI with the experts from Capgemini. You’re invited to register for any (or all!) presentations that spark your interest.

Please note: Registration for our presentations is open to all interested attendees. However, a valid HLTH Europe ticket is required to access the event (and our sessions). Registration for our presentations does not include a ticket to HLTH Europe.

Tuesday June 18

The second edition of the report investigates any notable shifts in connected health strategies and assesses the progress of biopharma companies in addressing their shortcomings and narrowing the maturity gap within their connected health portfolios over the past two years. It explores whether they are successfully scaling their connected health initiatives or encountering new challenges. Additionally, the scope of the research is broadened to examine the approach of MedTech companies to connected health, seeking insights into their current standing. Furthermore, the research delves into how newly emerging technologies, such as generative AI and immersive technologies, alongside collaboration with the wider health ecosystem, are propelling the connected health landscape forward.

  • Geoff McCleary, Global Connected Health Leader Capgemini
  • Vaishnavee Ananth, Senior Consultant, Capgemini Research Institute

Explore the cutting-edge of pharmaceutical innovation in action,” where we dive into how Generative AI is making waves in the industry. This presentation will walk you through a series of real-world use cases demonstrating GenAI’s pivotal role in the life sciences value chain. Discover firsthand the practical applications and transformative potential of GenAI technologies that are not just shaping the future of pharma but revolutionizing it today. Join us to see how these advancements are solving complex challenges and opening new avenues for health and healing.

  • Parvin Moyasari Amnieh, Global LS Lead Insights & Data, Capgemini

Discover how echOpen is transforming care with an affordable connected POCUS solution. Leveraging the latest advancements in connectivity, imaging, and computing, the innovative echOpen probe connects directly to smartphones, making ultrasound imaging accessible and affordable worldwide. This breakthrough technology promises to enhance medical diagnosis and care in primary care settings across the globe. Join us to learn about the collaboration with Capgemini Engineering and explore the future of healthcare and the impact of mobile ultrasound technology on patient care.

  • Olivier de Fresnoye, CEO and Co-founder of echOpen

Dive into the heart of innovation with “Pioneers of Health,” a dynamic session featuring a number of trailblazing startups of Future4Care. These rising stars will take the stage to share their revolutionary ideas and solutions that are set to redefine digital health.

  • Katherine Ossenkopp, Country Manager Future4care Germany

Wednesday June 19

Join us for a close look at Future4Care, where Europe’s brightest minds in tech and healthcare come together. In this session, we’ll share the story of how startups and big industry players across Europe team up under Future4Care’s roof to bring digital health innovations to life. Learn about the practical steps they take to turn bold ideas into real-world solutions, and see how their collaborative efforts are making healthcare better and more accessible for everyone. This is a chance to see how Future4Care is making a real difference in the way we think about health in our everyday lives.

  • Agnès de Leersnyder, CEO Future4Care
  • Katherine Ossenkopp, Country Manager Future4care Germany

This presentation will uncover what’s new in the subscription landscape, detailing how these models are being integrated into medical technology, their potential benefits, and the challenges they present. From enhancing patient care through continuous monitoring and support, to the financial implications for healthcare providers.

  • Geoff McCleary, Global Connected Health Leader Capgemini
Putting user experience at the core of evidence-based solutions to drive adoption and outcomes

This session will offer you an inspiring look into how NEN is revolutionizing pain management for children through the power of play and interactive gaming, the challenges of delivering patient centric digital solutions, and how a human centered approach can help cracking it.

Join us to learn more about NEN’s mission and the key challenges in their journey.

  • Dr. Francesca Wuttke, CEO and Founder of NEN
  • Chiara Diana, Chief Design Officer Frog, part of Capgemini Invent

Join us for an enlightening presentation on the transformative impact of Generative AI (GenAI) in clinical development, focusing on two pivotal areas: protocol design and regulatory submissions. Discover how GenAI is not only enhancing these processes but also revolutionizing the way we approach clinical trials for faster, more efficient outcomes.

  • David Ghesquieres, Global Clinical Development Lead Capgemini

Thursday June 20

This session will guide you through a number of use cases, illustrating GenAI’s impact on medical diagnostics, device innovation, patient care, and more. Experience up-close the practical deployments and transformative capabilities of GenAI.

  • Parvin Moyasari Amnieh, Global LS Lead Insights & Data, Capgemini

The second edition of the report investigates any notable shifts in connected health strategies and assesses the progress of biopharma companies in addressing their shortcomings and narrowing the maturity gap within their connected health portfolios over the past two years. It explores whether they are successfully scaling their connected health initiatives or encountering new challenges. Additionally, the scope of the research is broadened to examine the approach of MedTech companies to connected health, seeking insights into their current standing. Furthermore, the research delves into how newly emerging technologies, such as generative AI and immersive technologies, alongside collaboration with the wider health ecosystem, are propelling the connected health landscape forward.

  • Geoff McCleary, Global Connected Health Leader Capgemini
  • Vaishnavee Ananth, Senior Consultant, Capgemini Research Institute

Register now

Choose your sessions, mark your calendars, and get ready to join us in June. We can’t wait to see you there!

Sign up for our sessions

Research and insights

Capgemini Research Institute

Connected health research

Our speakers

Vaishnavee Ananth

Vaishnavee Ananth

Senior Consultant, Capgemini Research Institutee

Vaishnavee works closely with industry leaders and academics to inform clients about the impact of emerging technologies and evolving consumer behavior on their businesses and society.

Geoff McCleary

Geoff McCleary

Global Connected Health Leader, Capgemini

Geoff helps healthcare and life sciences leaders turn their connected health efforts into value-driving enterprises. He has over 25 years of experience in leading digital innovation, strategy, and marketing for global clients across the health ecosystem, from pharma and biotech to providers and payers.

Parvin Moyasari Amnieh

Parvin Moyasari Amnieh

Global Life Sciences Lead, Insights & Data, Capgemini

Parvin Moyasari is a focused executive with extensive experience in academic research, AI and data analytics, AI and digital transformation, business development, and project management.

Chiara Diana

Chiara Diana

Chiara Diana, Chief Design Officer, Head of Innovation Team, frog, part of Capgemini Invent

As Chief Design Officer, Head of Innovation team, Chiara is passionate about shaping innovation for complex product-service ecosystems, helping organizations embrace change and drive positive social transformations through design. She has been leading work in healthcare for 15+ years, helping large BioPharma, MedTech players and Digital visionaries, improve health outcomes through human-centered experiences.

Dr. Francesca Wuttke

Dr. Francesca Wuttke

CEO and Founder of Nen

As CEO and Founder of Nen, Dr. Wuttke brings evidence-based Digital Therapeutics (DTx) pain solutions to preschool kids with cancer. She also brings broad drug development and healthcare expertise in both the US and Europe, with over 25 years of clinical, commercial, strategic, and transactional experience.

Agnès de Leersnyder

Agnès de Leersnyder

CEO Future4Care

Agnès De Leersnyder is the CEO and co-founder of Future4care, the first digital healthcare ecosystem in Europe. Previously, she was Chief Strategy Officer of the Orange Group, where she developed and implemented the ‘Engage2025’ strategic plan. A humanist leader and a woman of strong convictions, Agnès has placed innovation and change management at the heart of her work for over 20 years in the Digital and New Technologies sector. She holds degrees from the Institute of Political Sciences in Strasbourg and ESCP, and she also holds a DEA in International Economic Law.

Katherine Ossenkopp

Katherine Ossenkopp

Country Manager Future4care Germany

Katherine is Country Manager Germany at Future4care, where she accelerates digital transformation in health care on behalf of Sanofi, Orange, Generali, Capgemini, and many more industrial partners. She provides hands-on advice for startups, scale-ups and corporates on business development, go-to-market strategies and partnering by leveraging Future4care’s ecosystem. Katherine holds a MSc in International Management from ESCP Europe and provides 15+ years of commercial experience in life sciences and innovation across Europe and the US. She is enthusiastic about shaping our healthcare system of the future. 

David Ghesquieres

David Ghesquieres

Global Clinical Development Lead Capgemini

David Ghesquieres leads the global Clinical Development practice at Capgemini and is a member of the Manufacturing & Life Sciences Executive Committee at Capgemini France. With over 25 years of expertise, David has mastered the oversight of consulting engagements and transformation programs in the Healthcare & Life Sciences industry. His broad experience encompasses leadership in multinational and multicultural settings, specializing in organizational change management across various sectors including global pharma, hospitals, and health authorities.

Olivier de Fresnoye

Olivier de Fresnoye

CEO and Co-founder of echOpen

Dive into HLTH themes

Connected health

By 2030, the global connected health market is expected to skyrocket to $181.9 billion, evolving at an impressive pace with a compound annual growth rate of over 22%. Yet, the journey is not without its hurdles. With approximately a quarter of connected medical devices facing FDA approval challenges and regulatory review times spanning 7 to 10 months, the race to market leadership is fraught with potential delays and setbacks. Recognizing these challenges, we’ve gathered a diverse collection of insightful content designed to enlighten and inspire your journey in connected health. Explore perspectives, breakthroughs, and discussions tailored for those at the forefront of medical innovation.

Unlocking the value of connected health

Just two years ago, Capgemini Research Institute published ites connected health maturity report, Unlocking the value in connected health: Why now is the time for biopharma companies to transform,  offering insights into the evolution of connected health.

Download the report

And we’re excited to announce that it’s time for an update: the latest advancements and findings will be unveiled on June 18 at the HLTH conference.

Accelerating SaMD go-to-market

In the field of healthcare systems compliance, the difference between 99% and 100% is a chasm.  As a legal manufacturer, we specialize in safety and compliance for Software as a Medical Device (SaMD). It’s a fast-growing field, with risks hiding in every nook and cranny. 

So how do we make sure we catch and neutralize every risk? How do we ensure safety and compliance, without sacrificing speed? Let’s dive in.

Read our expert perspective

The power of collaboration

Our collaboration with Phonak, a Sonova brand, has flourished into a remarkable journey of growth and innovation.

Together, we’ve embraced challenges, unlocked new opportunities, and evolved in sync with the fast-changing landscape of technology and healthcare.

Watch the video to learn more

Innovation – what’s next, and why it matters

Innovation isn’t just a buzzword—it’s changing the game for businesses and the world around us. We’re diving into what innovation really means for businesses today, especially when it comes to building a creative culture, tackling sustainability, and exploring cutting-edge tech like synthetic biology, the metaverse, quantum tech, and blockchain. Whether you’re looking to stay ahead of the curve in business or just curious about what the future holds, we’ve got interesting content for you.

CRISPR for a better world

The Capgemini Research Institute spoke with Dr. Jennifer Doudna, Nobel Prize laureate and Professor of Biomedical Science, University of California, Berkeley.

In this interview, Dr. Doudna offers a clear understanding of CRISPR and its applications, and talks about how CRISPR can be used for a better world.

Read the interview

Accelerating Medicine R&D Cycles

Capgemini and Sanofi set a new industry standard by accelerating clinical trials with the Act4Patients program.

Read the full story here

Generative AI

Generative AI (GenAI) and other forms of Artificial intelligence (AI) are creating new opportunities to reshape the future. In the world of the data economy, organizations are embracing new landscapes of connectivity, interactions, and creations. To stay ahead they are combining data with artificial intelligence, to explore new ways of working, producing, consuming and communicating – our future. Generative AI, with its extraordinary potential, is the new contributor to this shake-up.

But how can we experience the full transformational benefits of AI while remaining ethical, protecting society and the planet, and creating a more sustainable, trustworthy, and better future for everyone? 

Harnessing the value of Generative AI

People are excited about generative AI, eager to apply it in many areas of work and life, highlighting a growing interest in the technology. In our Capgemini Research Institute report, Harnessing the value of generative AI: Top use cases across industries, we delve into the transformative potential of the technology specifically from the perspective of organizations. 

Read our report

Generative AI for life sciences

Now is the time for life sciences organizations to plan their GenAI strategy and explore carefully selected use cases in a controlled environment, so they’re ready to reap this technology’s significant benefits while not exposing themselves to unnecessary risk.

Read our report

Explore and register for our sessions

You’re invited to register for any (or all!) presentations that spark your interest.

Register now